Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib with paclitaxel and carboplatin in HER2-positive breast cancer
NCT01309607Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Apr 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by National University Hospital. Status: unknown.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01309607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01309607.